top of page

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

ULY CLINIC

5 Agosti 2026, 11:47:52

Image-empty-state.png

Cocaine Withdrawal

Cocaine Withdrawal is a clinical syndrome that occurs after cessation or significant reduction of cocaine use in individuals who have developed psychological or physical dependence.


Unlike alcohol or opioid withdrawal, cocaine withdrawal is usually not associated with severe medical complications, but it may cause significant psychological distress, intense craving, depression, and increased risk of suicide.


Epidemiology

  • Cocaine withdrawal commonly occurs among individuals with regular or heavy cocaine use

  • Symptoms may occur within hours to days after stopping cocaine

  • The severity depends on the duration and intensity of cocaine use, route of administration, and individual factors

  • Depression and suicidal behaviour are important concerns during the withdrawal period


Risk factors

  • Long-term or heavy cocaine use

  • Previous episodes of cocaine withdrawal

  • Coexisting depression or other psychiatric disorders

  • History of suicidal behaviour

  • Use of multiple substances

  • Poor social support

  • Previous unsuccessful attempts to stop cocaine use


Pathophysiology

Cocaine increases dopamine, norepinephrine, and serotonin activity by blocking their reuptake in the central nervous system. Chronic cocaine exposure leads to neuroadaptation within reward pathways. When cocaine use stops, reduced dopamine activity contributes to fatigue, depressed mood, reduced pleasure, craving, and other withdrawal symptoms.


Clinical presentation

Symptoms usually begin within hours to a few days after stopping cocaine and may persist for several weeks.


Common withdrawal symptoms

  • Depressed mood

  • Fatigue

  • Reduced energy

  • Increased sleep or insomnia

  • Anxiety

  • Irritability

  • Restlessness

  • Strong craving for cocaine

  • Poor concentration

  • Increased appetite


Important clinical concerns

  • Major depressive symptoms

  • Suicidal thoughts or behaviour

  • Psychotic symptoms in some individuals

  • Risk of relapse due to intense craving


Diagnostic criteria

Diagnosis is clinical and requires:

  • Cessation or reduction of prolonged cocaine use

  • Development of characteristic withdrawal symptoms after stopping cocaine use

  • Symptoms causing significant distress or impairment

Withdrawal features include:

  • Dysphoric mood

  • Fatigue

  • Vivid unpleasant dreams

  • Insomnia or excessive sleep

  • Increased appetite

  • Psychomotor agitation or retardation

  • Craving for cocaine

Assessment should include evaluation for depression and suicide risk.


Differential diagnosis

  • Major depressive disorder

  • Stimulant-induced depressive disorder

  • Alcohol withdrawal

  • Opioid withdrawal

  • Adjustment disorder

  • Other substance withdrawal syndromes

  • Medical conditions causing fatigue or mood changes


Investigations

Cocaine withdrawal is diagnosed clinically.

Assessment should include:


Clinical assessment

  • Detailed history of cocaine use

  • Assessment of withdrawal symptoms

  • Mental status examination

  • Suicide risk assessment

  • Assessment of other substance use


Laboratory investigations (when indicated)

  • Urine drug screening

  • Blood glucose

  • Full blood count

  • Electrolytes

  • Renal and liver function tests where clinically indicated


Management


Treatment goals

  • Support safe withdrawal

  • Monitor and treat depression

  • Prevent relapse

  • Address psychosocial factors contributing to cocaine use


Non-pharmacological Management

  • Most patients do not require hospital admission

  • Provide supportive counselling and reassurance

  • Monitor for depression and assess suicide risk

  • Provide psychoeducation regarding withdrawal symptoms

  • Encourage participation in substance use counselling programmes

  • Provide relapse prevention strategies

  • Encourage family and social support

  • Refer for psychological therapies where available


Pharmacological management

There is no approved substitute medication for cocaine detoxification.

For management of anxiety, agitation, or sleep disturbance:

Diazepam 5–10 mg orally every 8 hours for 5–7 days.

Notes:

  • Medication should be titrated according to symptom resolution

  • Use short-term only due to risk of dependence

  • Monitor for sedation and respiratory depression

  • Avoid prolonged benzodiazepine use

Management of depressive symptoms should follow the relevant treatment guidelines for depressive disorders.


Referral criteria

Refer to specialized clinic if:

  • Significant depressive symptoms

  • Suicidal thoughts or behaviour

  • Severe psychiatric symptoms

  • Persistent cocaine craving

  • Recurrent relapse

  • Coexisting substance use disorders

  • Need for specialized addiction treatment


Complications

  • Major depressive episodes

  • Suicide attempts

  • Relapse to cocaine use

  • Cocaine overdose after relapse due to reduced tolerance

  • Social and occupational impairment

  • Coexisting substance use disorders


Prevention

  • Early identification of cocaine use disorder

  • Access to addiction treatment services

  • Psychological support and relapse prevention programmes

  • Screening and treatment of mental health disorders

  • Family and community support


Prognosis

Cocaine withdrawal symptoms generally improve with supportive care. However, relapse risk remains high, especially during periods of intense craving and depressive symptoms. Long-term recovery improves with continued psychosocial treatment and addiction support.


Patient education

  • Cocaine withdrawal can cause significant mood changes but is treatable

  • Depression and suicidal thoughts require urgent medical attention

  • Avoid returning to cocaine use after stopping because relapse may increase overdose risk

  • Counselling and rehabilitation improve long-term recovery

  • Attend follow-up appointments and addiction support services

Imeandikwa:

5 Agosti 2026, 11:46:48

Disclaimer: The information on this website is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for medical concerns or emergencies.

Rejea za mada hii:

  • United Republic of Tanzania, Ministry of Health. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland. 6th ed. Dodoma: Ministry of Health; 2021.

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Text Revision. Washington, DC: American Psychiatric Association Publishing; 2022.

  • World Health Organization. International Standards for the Treatment of Drug Use Disorders: Revised Edition Incorporating Results of Field-Testing. Geneva: World Health Organization; 2020.

  • National Institute on Drug Abuse. Treatment Approaches for Drug Addiction and Substance Use Disorders. Bethesda: National Institutes of Health; 2024.

bottom of page